Treatment of mammalian cells with the immunosuppressant rapamycin, a b
acterial macrolide, selectively suppresses mitogen-induced translation
of an essential class of mRNAs which contain an oligopyrimidine tract
at their transcriptional start (5'TOP), most notably mRNAs encoding r
ibosomal proteins and elongation factors. In parallel, rapamycin block
s mitogen-induced p70 ribosomal protein S6 kinase (p70(s6k)) phosphory
lation and activation. Utilizing chimeric mRNA constructs containing e
ither a wildtype or disrupted 5'TOP, we demonstrate that an intact pol
ypyrimidine tract is required for rapamycin to elicit an inhibitory ef
fect on the translation of these transcripts. In turn, a dominant-inte
rfering p70(s6k), which selectively prevents p70(s6k) activation by bl
ocking phosphorylation of the rapamycin-sensitive sites, suppresses th
e translation of the chimeric mRNA containing the wild-type but not th
e disrupted 5'TOP. Conversion of the principal rapamycin-sensitive p70
(s6k) phosphorylation site, T389, to an acidic residue confers rapamyc
in resistance on the kinase and negates the inhibitory effects of the
macrolide on 5'TOP mRNA translation in cells expressing this mutant. T
he results demonstrate that the rapamycin block of mitogen induced 5'T
OP mRNA translation is mediated through inhibition of p70(s6k) activat
ion.